-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Minimed Group, Lowers Price Target to $22

Benzinga·06/04/2026 13:09:53
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and lowers the price target from $26 to $22.